ATXS
Price
$5.44
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
314.34M
42 days until earnings call
ZIVO
Price
$14.91
Change
+$0.69 (+4.85%)
Updated
Jun 24 closing price
Capitalization
56.86M
Interact to see
Advertisement

ATXS vs ZIVO

Header iconATXS vs ZIVO Comparison
Open Charts ATXS vs ZIVOBanner chart's image
Astria Therapeutics
Price$5.44
Change-$0.00 (-0.00%)
Volume$50
Capitalization314.34M
Zivo Bioscience
Price$14.91
Change+$0.69 (+4.85%)
Volume$516
Capitalization56.86M
ATXS vs ZIVO Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. ZIVO commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Buy and ZIVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ATXS: $5.44 vs. ZIVO: $14.91)
Brand notoriety: ATXS and ZIVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 0% vs. ZIVO: 35%
Market capitalization -- ATXS: $314.34M vs. ZIVO: $56.86M
ATXS [@Biotechnology] is valued at $314.34M. ZIVO’s [@Biotechnology] market capitalization is $56.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileZIVO’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • ZIVO’s FA Score: 0 green, 5 red.
According to our system of comparison, ATXS is a better buy in the long-term than ZIVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 6 TA indicator(s) are bullish while ZIVO’s TA Score has 4 bullish TA indicator(s).

  • ATXS’s TA Score: 6 bullish, 4 bearish.
  • ZIVO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than ZIVO.

Price Growth

ATXS (@Biotechnology) experienced а -7.17% price change this week, while ZIVO (@Biotechnology) price change was +4.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.66%. For the same industry, the average monthly price growth was +32.94%, and the average quarterly price growth was +6.79%.

Reported Earning Dates

ATXS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($314M) has a higher market cap than ZIVO($56.9M). ZIVO YTD gains are higher at: -30.651 vs. ATXS (-39.150). ZIVO has higher annual earnings (EBITDA): -16.29M vs. ATXS (-124.4M). ATXS has more cash in the bank: 295M vs. ZIVO (517K). ZIVO has less debt than ATXS: ZIVO (975K) vs ATXS (5.06M). ZIVO has higher revenues than ATXS: ZIVO (122K) vs ATXS (0).
ATXSZIVOATXS / ZIVO
Capitalization314M56.9M552%
EBITDA-124.4M-16.29M763%
Gain YTD-39.150-30.651128%
P/E RatioN/AN/A-
Revenue0122K-
Total Cash295M517K57,060%
Total Debt5.06M975K519%
FUNDAMENTALS RATINGS
ATXS vs ZIVO: Fundamental Ratings
ATXS
ZIVO
OUTLOOK RATING
1..100
7650
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6056
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATXS's Valuation (59) in the Biotechnology industry is in the same range as ZIVO (82) in the null industry. This means that ATXS’s stock grew similarly to ZIVO’s over the last 12 months.

ATXS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ZIVO (100) in the null industry. This means that ATXS’s stock grew similarly to ZIVO’s over the last 12 months.

ATXS's SMR Rating (97) in the Biotechnology industry is in the same range as ZIVO (100) in the null industry. This means that ATXS’s stock grew similarly to ZIVO’s over the last 12 months.

ZIVO's Price Growth Rating (56) in the null industry is in the same range as ATXS (60) in the Biotechnology industry. This means that ZIVO’s stock grew similarly to ATXS’s over the last 12 months.

ZIVO's P/E Growth Rating (100) in the null industry is in the same range as ATXS (100) in the Biotechnology industry. This means that ZIVO’s stock grew similarly to ATXS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATXSZIVO
RSI
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYDVF0.220.01
+5.19%
CENTURY LITHIUM CORP.
GEAHF1.69N/A
N/A
Great Eagle Holdings Ltd.
IVSBF28.28N/A
N/A
Investors AB
BVAXF0.03N/A
N/A
BioVaxys Technology Corp.
TKAMY10.60-0.01
-0.09%
ThyssenKrupp AG

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with DNLI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
N/A
DNLI - ATXS
57%
Loosely correlated
-2.69%
CRNX - ATXS
54%
Loosely correlated
-0.10%
XENE - ATXS
54%
Loosely correlated
+0.62%
TRDA - ATXS
53%
Loosely correlated
-1.57%
APGE - ATXS
52%
Loosely correlated
N/A
More

ZIVO and

Correlation & Price change

A.I.dvisor tells us that ZIVO and MDXXF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZIVO and MDXXF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZIVO
1D Price
Change %
ZIVO100%
N/A
MDXXF - ZIVO
22%
Poorly correlated
+7.07%
ATXS - ZIVO
21%
Poorly correlated
N/A
ETXPF - ZIVO
21%
Poorly correlated
N/A
COGT - ZIVO
20%
Poorly correlated
-3.14%
CLSD - ZIVO
20%
Poorly correlated
-5.06%
More